Literature DB >> 21873229

Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions.

Jianglei Chen1, Qianqian Li, Jianjun Wang.   

Abstract

Human apolipoprotein E (apoE) is one of the major determinants in lipid transport, playing a critical role in atherosclerosis and other diseases. Binding to lipid and heparan sulfate proteoglycans (HSPG) induces apoE to adopt active conformations for binding to low-density lipoprotein receptor (LDLR) family. ApoE also interacts with beta amyloid peptide, manifests critical isoform-specific effects on Alzheimer's disease. Despite the importance of apoE in these major human diseases, the fundamental questions of how apoE adjusts its structure upon binding to regulate its diverse functions remain unsolved. We report the NMR structure of apoE3, displaying a unique topology of three structural domains. The C-terminal domain presents a large exposed hydrophobic surface that likely initiates interactions with lipids, HSPG, and beta amyloid peptides. The unique topology precisely regulates apoE tertiary structure to permit only one possible conformational adaptation upon binding and provides a double security in preventing lipid-free and partially-lipidated apoE from premature binding to apoE receptors during receptor biogenesis. This topology further ensures the optimal receptor-binding activity by the fully lipidated apoE during lipoprotein transport in circulation and in the brain. These findings provide a structural framework for understanding the structural basis of the diverse functions of this important protein in human diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873229      PMCID: PMC3169138          DOI: 10.1073/pnas.1106420108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor.

Authors:  J A Morrow; K S Arnold; J Dong; M E Balestra; T L Innerarity; K H Weisgraber
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3.

Authors:  V Narayanaswami; S S Szeto; R O Ryan
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

3.  Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.

Authors:  Trevor D Burt; Brian K Agan; Vincent C Marconi; Weijing He; Hemant Kulkarni; Jeffrey E Mold; Marielle Cavrois; Yadong Huang; Robert W Mahley; Matthew J Dolan; Joseph M McCune; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

4.  A complete backbone spectral assignment of lipid-free human apolipoprotein E (apoE).

Authors:  Yonghong Zhang; Jianglei Chen; Jianjun Wang
Journal:  Biomol NMR Assign       Date:  2008-10-04       Impact factor: 0.746

5.  Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

6.  Molecular mechanism of apolipoprotein E binding to lipoprotein particles.

Authors:  David Nguyen; Padmaja Dhanasekaran; Michael C Phillips; Sissel Lund-Katz
Journal:  Biochemistry       Date:  2009-04-07       Impact factor: 3.162

7.  An efficient on-column expressed protein ligation strategy: application to segmental triple labeling of human apolipoprotein E3.

Authors:  Wentao Zhao; Yonghong Zhang; Chunxian Cui; Qianqian Li; Jianjun Wang
Journal:  Protein Sci       Date:  2008-02-27       Impact factor: 6.725

8.  Type 2 diabetes mellitus and its renal complications in relation to apolipoprotein E gene polymorphism.

Authors:  Shuk-Woon Ma; Iris F F Benzie; Vincent T F Yeung
Journal:  Transl Res       Date:  2008-08-12       Impact factor: 7.012

Review 9.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.

Authors:  Guojun Bu
Journal:  Nat Rev Neurosci       Date:  2009-04-02       Impact factor: 34.870

10.  A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity.

Authors:  Arun Sivashanmugam; Jianjun Wang
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

View more
  101 in total

1.  Depressed neurofilament expression associates with apolipoprotein E3/E4 genotype in maturing human fetal neurons exposed to HIV-1.

Authors:  Ricardo Martinez; Wu Chunjing; Rebeca Geffin; Micheline McCarthy
Journal:  J Neurovirol       Date:  2012-08       Impact factor: 2.643

2.  Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4.

Authors:  Chiharu Mizuguchi; Mami Hata; Padmaja Dhanasekaran; Margaret Nickel; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2012-07-03       Impact factor: 3.162

3.  The extent of pyrene excimer fluorescence emission is a reflector of distance and flexibility: analysis of the segment linking the LDL receptor-binding and tetramerization domains of apolipoprotein E3.

Authors:  Gursharan K Bains; Sea H Kim; Eric J Sorin; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2012-07-26       Impact factor: 3.162

4.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

5.  O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain.

Authors:  Sarah A Flowers; Oliver C Grant; Robert J Woods; G William Rebeck
Journal:  Glycobiology       Date:  2020-01-28       Impact factor: 4.313

Review 6.  ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

Authors:  Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

7.  Allele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles.

Authors:  Dimitra Georgiadou; Angeliki Chroni; Konstantinos Drosatos; Kyriakos E Kypreos; Vassilis I Zannis; Efstratios Stratikos
Journal:  Atherosclerosis       Date:  2012-11-23       Impact factor: 5.162

8.  A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes.

Authors:  Tamayo Kato; Yasuyuki Ushiogi; Hitoshi Yokoyama; Shigeo Hara; Akira Matsunaga; Eri Muso; Takao Saito
Journal:  CEN Case Rep       Date:  2019-01-30

9.  Peptide-Level Interactions between Proteins and Small-Molecule Drug Candidates by Two Hydrogen-Deuterium Exchange MS-Based Methods: The Example of Apolipoprotein E3.

Authors:  Hanliu Wang; Don L Rempel; Daryl Giblin; Carl Frieden; Michael L Gross
Journal:  Anal Chem       Date:  2017-09-25       Impact factor: 6.986

10.  Solution structure of the two RNA recognition motifs of hnRNP A1 using segmental isotope labeling: how the relative orientation between RRMs influences the nucleic acid binding topology.

Authors:  Pierre Barraud; Frédéric H-T Allain
Journal:  J Biomol NMR       Date:  2012-12-18       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.